Nuvalent, Inc. is a biopharmaceutical company focusing on developing targeted cancer therapies. Despite being ranked 4th on the list of worst cancer stocks by short sellers, Nuvalent has strong market interest and potential.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing